Updates are available Correction dated 2024-11-29
Click to view Correction: https://doi.org/10.1038/s41586-024-08452-3
-
Authors
Monje, Michelle https://orcid.org/0000-0002-3547-237X
Mahdi, Jasia
Majzner, Robbie https://orcid.org/0000-0001-6969-8011
Yeom, Kristen W. https://orcid.org/0000-0001-9860-3368
Schultz, Liora M.
Richards, Rebecca M.
Barsan, Valentin
Song, Kun-Wei https://orcid.org/0000-0002-4472-230X
Kamens, Jen
Baggott, Christina
Kunicki, Michael https://orcid.org/0000-0001-6630-6289
Rietberg, Skyler P.
Lim, Alexandria Sung
Reschke, Agnes
Mavroukakis, Sharon
Egeler, Emily https://orcid.org/0000-0001-5173-0335
Moon, Jennifer
Patel, Shabnum
Chinnasamy, Harshini
Erickson, Courtney
Jacobs, Ashley
Duh, Allison K.
Tunuguntla, Ramya
Klysz, Dorota Danuta https://orcid.org/0000-0002-6733-6110
Fowler, Carley
Green, Sean
Beebe, Barbara
Carr, Casey
Fujimoto, Michelle
Brown, Annie Kathleen
Petersen, Ann-Louise G.
McIntyre, Catherine
Siddiqui, Aman
Lepori-Bui, Nadia
Villar, Katlin
Pham, Kymhuynh
Bove, Rachel
Musa, Eric
Reynolds, Warren D.
Kuo, Adam
Prabhu, Snehit
Rasmussen, Lindsey
Cornell, Timothy T.
Partap, Sonia
Fisher, Paul G. https://orcid.org/0000-0002-1196-1590
Campen, Cynthia J. https://orcid.org/0000-0002-3519-1375
Grant, Gerald
Prolo, Laura
Ye, Xiaobu
Sahaf, Bita
Davis, Kara L. https://orcid.org/0000-0002-7182-2592
Feldman, Steven A.
Ramakrishna, Sneha https://orcid.org/0000-0001-7445-3190
Mackall, Crystal https://orcid.org/0000-0001-6323-4304
- License Information
-
More Information
Article History
Received: 19 June 2024
Accepted: 8 October 2024
First Online: 13 November 2024
Change Date: 27 May 2025
Change Type: Update
Change Details: This paper was originally published under Creative Commons Attribution 4.0 International license, CC-BY-NC-ND, © The Author(s). It is now available under a Creative Commons Attribution 4.0 International license, CC-BY, © The Author(s). The error has been corrected in the online version of the article.
Change Date: 29 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-08452-3
Competing interests
: M.M., R.M. and C. Mackall are coinventors on a patent for the use of GD2-CAR T cells in regard to H2K27M gliomas, coordinated through Stanford University. C. Mackall is a coinventor on patents for the use of dasatinib and other small molecules to modulate CAR function and control CAR-associated toxicity, and on several patents related to CAR T cell therapies. C. Mackall holds equity in CARGO Therapeutics, Link Cell Therapies and GBM Newco, which are developing CAR-based therapies, and consults for CARGO, Link, Immatics, Ensoma, GBM NewCo and Red Tree Capital. She receives research funding from Lyell and Tune Therapeutics. R.M. is a cofounder of, and holds equity in, Link Cell Therapies and CARGO Therapeutics, and is a consultant for Lyell Immunopharma, NKarta, Arovella Pharmaceuticals, Innervate Radiopharmaceuticals, Aptorum Group, Gadeta, FATE Therapeutics (Data and Safety Monitoring Board) and Waypoint Bio. S.A.F. holds several patents in the field of cellular immunotherapy. V.B. is an investor and Director at Umoja Biopharma and Arsenal Bio. S.P.R. holds equity in Lyell Immunopharma. M.M. holds equity in MapLight Therapeutics and CARGO Therapeutics. The other authors declare no competing interests.
